We are live on ! Find out more
MIFH

Migdal Insurance & Financial Holdings Portfolio holdings

AUM $15.6B
1-Year Est. Return 71.29%
This Fund
S&P 500
This Quarter Est. Return
+9.91%
1 Year Est. Return
+71.29%
3 Year Est. Return
+173.57%
5 Year Est. Return
+196.76%
10 Year Est. Return
+800.33%
AUM
$9.54B
AUM Growth
-$384M
Cap. Flow
-$1.1B
Cap. Flow %
-11.51%
Top 10 Hldgs %
34.97%
Holding
704
New
37
Increased
192
Reduced
239
Closed
122

Sector Composition

Rank Sector Weight
1 Technology 23.54%
2 Consumer Discretionary 9.15%
3 Financials 8.1%
4 Communication Services 8.01%
5 Industrials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VFC icon
676
VF Corp
VFC
$5.79B
-345,096
Closed -$27.6M
VRSK icon
677
Verisk Analytics
VRSK
$24.2B
-306
Closed -$54K
VTRS icon
678
Viatris
VTRS
$18.4B
-3,926
Closed -$55K
WAB icon
679
Wabtec
WAB
$50.3B
$0 ﹤0.01%
+1
New +$81
WDC icon
680
Western Digital
WDC
$168B
-2,455
Closed -$124K
WEN icon
681
Wendy's
WEN
$1.65B
-1,500,000
Closed -$30.4M
WST icon
682
West Pharmaceutical
WST
$24.4B
-174
Closed -$49K
TECX
683
Tectonic Therapeutic
TECX
$664M
-4,220
Closed -$643K
SCWX
684
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
-87,351
Closed -$1.17M
NSTG
685
DELISTED
NanoString Technologies, Inc.
NSTG
-11,883
Closed -$781K
NVTA
686
DELISTED
Invitae Corporation
NVTA
-13,544
Closed -$518K
CFIVW
687
DELISTED
CF Acquisition Corp. IV Warrant
CFIVW
-376,333
Closed -$331K
CFIVU
688
DELISTED
CF Acquisition Corp. IV Unit
CFIVU
$0 ﹤0.01%
1
SRNE
689
DELISTED
Sorrento Therapeutics, Inc.
SRNE
-85,086
Closed -$704K
CLVS
690
DELISTED
Clovis Oncology, Inc.
CLVS
-416
Closed -$3K
EPZM
691
DELISTED
Epizyme, Inc
EPZM
-52,164
Closed -$454K
CERN
692
DELISTED
Cerner Corp
CERN
-599
Closed -$43K
EPAY
693
DELISTED
Bottomline Technologies Inc
EPAY
$0 ﹤0.01%
9
-29
-76% -$1.2K
RDS.A
694
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
-330
Closed -$13K
DRNA
695
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-27,455
Closed -$702K
IACB.U
696
DELISTED
ION Acquisition Corp 2 Ltd. Units, each consisting of one Class A ordinary share and one-eighth of o
IACB.U
-1,268,308
Closed -$12.9M
TBIO
697
DELISTED
Translate Bio, Inc. Common Stock
TBIO
-30,852
Closed -$509K
VCVC
698
DELISTED
10X Capital Venture Acquisition Corp
VCVC
-981,665
Closed -$9.82M
LMNX
699
DELISTED
Luminex Corp
LMNX
-28,150
Closed -$898K
IACA
700
DELISTED
ION Acquisition Corp 1 Ltd.
IACA
-627,026
Closed -$6.34M

Similar funds

Migdal Insurance & Financial Holdings's Q2 2021 Portfolio in Review

As of Q2 2021, Migdal Insurance & Financial Holdings held 704 positions worth $9.54B, down 3.9% from $9.92B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Migdal Insurance & Financial Holdings withdrew a net $1.1B in Q2 2021, closing 122 positions and reducing 239 holdings. Its most notable exit was State Street SPDR S&P Bank ETF, an estimated $332M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Migdal Insurance & Financial Holdings opened a new position in iShares MSCI Brazil ETF worth $68.8M.

  • Migdal Insurance & Financial Holdings's largest Q2 2021 buy was iShares MSCI Brazil ETF: 1,697,007 shares worth $68.8M.
  • Migdal Insurance & Financial Holdings added most to Apple in Q2 2021, an estimated $71.5M increase.
  • Migdal Insurance & Financial Holdings's biggest Q2 2021 reduction was Vanguard Russell 2000 ETF, cutting an estimated $196M.
  • Migdal Insurance & Financial Holdings fully exited State Street SPDR S&P Bank ETF in Q2 2021, selling an estimated $332M.
  • Migdal Insurance & Financial Holdings's ten largest holdings make up 35% of its $9.54B portfolio in Q2 2021.
  • Migdal Insurance & Financial Holdings opened 37 new positions and closed 122 in Q2 2021.
  • Migdal Insurance & Financial Holdings's portfolio value fell 3.9% quarter-over-quarter to $9.54B.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.